Vision loss in younger patients: A review of choroidal neovascularization

Optometry and Vision Science

Volumn 83, Issue 5, 2006, Pages 316-325

  Miller, David G ^a   Singerman, Lawrence J ^a  

^a Retina Associates of Cleveland   (United States)

Author keywords

Choroidal neovascularization; Management; Ocular histoplasmosis syndrome; Optometrist; Pathologic myopia; Referral; Verteporfin

Indexed keywords

DETERIORATION; OPTOMETERS; PATIENT MONITORING; PATIENT REHABILITATION; RISK ASSESSMENT;

CHOROIDAL NEOVASCULARIZATION; OCULAR HISTOPLASMOSIS SYNDROME; OPTOMETRIST; PATHOLOGIC MYOPIA; REFERRAL; VERTEPORFIN;

VISION;

BENZOPORPHYRIN DERIVATIVE;

ANGIOID STREAK; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DRUG EFFECT; DRUG EFFICACY; DRUSEN; EARLY DIAGNOSIS; HUMAN; INJECTION SITE REACTION; LASER COAGULATION; LONG TERM CARE; MYOPIA; OCULAR HISTOPLASMOSIS; OPTIC NERVE DISEASE; OPTOMETRY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; PROGNOSIS; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; RETINA MACULA VITELLIFORM DEGENERATION; RETINA SURGERY; REVIEW; RISK FACTOR; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY DECREASE; VISUAL DISORDER; VISUAL IMPAIRMENT;

AGE FACTORS; CHOROIDAL NEOVASCULARIZATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; VISION, LOW; VISUAL ACUITY;

EID: 33744491282     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.opx.0000216019.88256.eb     Document Type: Review

References (47)

1. Spaide RF. Choroidal neovascularization in younger patients. Curr Opin Ophthalmol 1999;10:177-81.
2. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996;103:1241-4.
3. Miller DG, Singerman LJ. Natural history of choroidal neovascularization in high myopia. Curr Opin Ophthalmol 2001;12:222-4.
4. Verteporfin In Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001;108:841-52.
5. Secretan M, Kuhn D, Soubrane G, Coscas G. Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol 1997;7:307-16.
6. Olk RJ, Burgess DB, McCormick PA. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis. Ophthalmology 1984;91:1592-602.
7. Fine SL, Wood WJ, Isernhagen RD, Singerman LJ, Bressler NM, Folk JC, Kimura AE, Fish GE, Maguire MG, Alexander J. Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial. Arch Ophthalmol 1993;111:19-20.
8. Gurwood AS, Mastrangelo DL. Understanding angioid streaks. J Am Optom Assoc 1997;68:309-24.
9. Kent D, Sheridan C. Choroidal neovascularization: a wound healing perspective. Mol Vis 2003;9:747-55.
10. Klein RM, Green S. The development of lacquer cracks in pathologic myopia. Am J Ophthalmol 1988;106:282-5.
11. Clarkson JG, Altman RD. Angioid streaks. Surv Ophthalmol 1982;26:235-46.
12. Donaldson EJ. Angioid streaks. Aust J Ophthalmol 1983;11:55-8.
13. Kuo IC, Cunningham ET Jr. Ocular neovascularization in patients with uveitis. Int Ophthalmol Clin 2000;40:111-26.
14. Marano F, Deutman AF, Leys A, Aandekerk AL. Hereditary retinal dystrophies and choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2000;238:760-4.
15. Mattice E, Wolfe CP. Using the Amsler grid. J Ophthalmic Nurs Technol 1986;5:34.
16. Haddad WM, Coscas G, Soubrane G. Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration. Br J Ophthalmol 2002;86:663-9.
17. Ohno-Matsui K, Morishima N, Ito M, Tokoro T. Indocyanine green angiographic findings of lacquer cracks in pathologic myopia. Jpn J Ophthalmol 1998;42:293-9.
18. Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 2003;110:15-21.
19. Gragoudas ES, Adamis AP, Cunningham ET, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16.
20. Verteporfin Roundtable Participants. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update. Retina 2005;25:119-34.
21. Soubrane G, Pison J, Bornert P, Perrenoud F, Coscas G. [Subretinal neovessels in degenerative myopia: results of photocoagulation.] Bull Soc Ophtalmol Fr 1986;86:269-72.
22. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Arch Ophthalmol 1987;105:1499-507.
23. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Arch Ophthalmol 1989;107:344-52.
24. Macular Photocoagulation Study Group. Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Arch Ophthalmol 1990;108:832-7.
25. Pece A, Avanza P, Galli L, Brancato R. Laser photocoagulation of choroidal neovascularization in angioid streaks. Retina 1997;17:12-6.
26. Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 1984;91:1573-81.
27. Jalkh AE, Weiter JJ, Trempe CL, Pruett RC, Schepens CL. Choroidal neovascularization in degenerative myopia: role of laser photocoagulation. Ophthalmic Surg 1987;18:721-5.
28. Verteporfin In Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial - VIP report no. 3. Ophthalmology 2003;110:667-73.
29. Bandello F, Blinder K, Bressler NM, Brown AL, Miller JW, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Slakter JS, Soubrane G, Strong HA, Stur M. Verteporfin in Photodynamic Therapy: report no. 5. Ophthalmology 2004;111:2144.
30. Rosenfeld PJ, Saperstein DA, Bressler NM, Reaves TA, Sickenberg M, Rosa RH Jr, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study. Ophthalmology 2004;111:1725-33.
31. Saperstein DA, Rosenfeld PJ, Bressler NM, Rosa RH Jr, Sickenberg M, Sternberg P Jr, Aaberg TM Sr, Aaberg TM Jr, Reaves TA. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology 2002;109:1499-505.
32. Busquets MA, Shah GK, Wickens J, Callanan D, Blinder KJ, Burgess D, Grand MG, Holekamp NM, Boniuk I, Joseph DP, Thomas MA, Fish E, Bakal J, Hollands H, Sharma S. Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina 2003;23:299-306.
33. Hershberger VS, Hutchins RK, Laber PW. Photodynamic therapy with verteporfin for subretinal neovascularization secondary to bilateral idiopathic acquired juxtafoveolar telangiectasis. Ophthalmic Surg Lasers Imaging 2003;34:318-20.
34. Karacorlu M, Karacorlu S, Ozdemir H, Mat C. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 2002;134:360-6.
35. Menchini U, Virgili G, Introini U, Bandello F, Ambesi-Impiombato M, Pece A, Parodi MB, Giacomelli G, Capobianco B, Varano M, Brancato R. Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina 2004;24:763-71.
36. Mimouni KF, Bressler SB, Bressler NM. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children. Am J Ophthalmol 2003;135:900-2.
37. Potter MJ, Szabo SM, Chan EY, Morris AH. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 2002;133:149-51.
38. Rogers AH, Duker JS, Nichols N, Baker BJ. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 2003;110:1315-20.
39. Shaikh S, Ruby AJ, Williams GA. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. Am J Ophthalmol 2003;135:1-6.
40. Sickenberg M, Schmidt-Erfurth U, Miller JW, Pournaras CJ, Zografos L, Piguet B, Donati G, Laqua H, Barbazetto I, Gragoudas ES, Lane AM, Birngruber R, van den Bergh H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000;118:327-36.
41. Spaide RF, Martin ML, Slakter J, Yannuzzi LA, Sorenson J, Guyer DR, Freund KB. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol 2002;134:62-8.
42. Rubin GS, Bressler NM. Effects of verteporfin therapy on contrast on sensitivity: results from the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) investigation - TAP report No 4. Retina 2002;22:536-44.
43. Fletcher DC, Schuchard RA, Walker JP, Wing GL, Raskauskas PA, Ghuman TA. SLO macular scotoma size benefitted by PDT. Invest Ophthalmol Vis Sci 2002;43:E-Abstract 3979.
44. Bressler SB, Burdan A, Haynes L, Lim JI, Miller JW, Potter MJ, Reaves A, Rosenfeld PJ, Sickenberg M, Slakter JS, Soubrane G, Strong HA, Stur M. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials - TAP and VIP report no. 3. Am J Ophthalmol 2004;137:683-96.
45. Davidorf FH, Hoskins JC, Marsh MJ, Miskala PH, Redford M, Sternberg P, Jr., Thomas MA, Toth CA. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9. Arch Ophthalmol 2004;122:1597-611.
46. Bottoni F, Airaghi P, Perego E, Ortolina S, Carlevaro G, De Molfetta V. Surgical removal of idiopathic, myopic and age-related subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol 1996;234 (suppl 1):S42-50.
47. Margrain TH. Helping blind and partially sighted people to read: the effectiveness of low vision aids. Br J Ophthalmol 2000;84:919-21.